We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.92B
AUM Growth
+$79.1M
(+2.8%)
Cap. Flow
-$811M
Cap. Flow
% of AUM
-27.73%
Top 10 Holdings %
Top 10 Hldgs %
45.84%
Holding
71
New
6
Increased
13
Reduced
17
Closed
13
Top Buys
| 1 |
CAI
Caris Life Sciences
CAI
|
+$197M |
| 2 |
Krystal Biotech
KRYS
|
+$48M |
| 3 |
Edgewise Therapeutics
EWTX
|
+$39.7M |
| 4 |
Inspire Medical Systems
INSP
|
+$31.9M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$29.2M |
Top Sells
| 1 |
Transmedics
TMDX
|
+$65.9M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$38.9M |
| 3 |
iRhythm Holdings
IRTC
|
+$33.1M |
| 4 |
BCAX
Bicara Therapeutics
BCAX
|
+$28.2M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
+$21.9M |
Sector Composition
| 1 | Healthcare | 71.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ironwood Pharmaceuticals
IRWD
$635M
| – | – |
-6,622,584
| Closed | -$9.74M |
|
52
Sarepta Therapeutics
SRPT
$1.87B
| – | – |
-234,500
| Closed | -$15M |
|
53
Trevi Therapeutics
TRVI
$2.5B
| – | – |
-72,083
| Closed | -$453K |
|
54
Skye Bioscience
SKYE
$22.1M
| – | – |
-825,732
| Closed | -$1.31M |
|
|
BCAX
55
Bicara Therapeutics
BCAX
$1.8B
| – | – |
-2,162,803
| Closed | -$28.2M |
|
|
BBNX
56
Beta Bionics
BBNX
$765M
| – | – |
-140,000
| Closed | -$1.71M |
|
|
MTSR
57
DELISTED
Metsera Inc
MTSR
| – | – |
-175,000
| Closed | -$4.76M |
|
|
AARD
58
Aardvark Therapeutics
AARD
$136M
| – | – |
-500,000
| Closed | -$3.75M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM